The Randomized OPTIMAL-ACT Trial
Conditions: Coronary Artery Disease; Ischemic Heart Disease; Anticoagulant-induced Bleeding; Coronary Syndrome Intervention: Drug: Unfractionated heparin Sponsor: Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials